Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 2, 1996, Pages 588-595

  Jordana, Gloria ^a   Dolovich, Jerry ^a   Briscoe, Maureen P ^b   Day, James H ^b   Drouin, Michel A ^c   Gold, Milton ^d   Robson, Reid ^e   Stepner, Nate ^e   Yang, William ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e GLAXOSMITHKLINE   (Canada)

Author keywords

antihistamine; Fluticasone propionate; intranasal corticosteroid; loratadine; nasal peak inspiratory flow; seasonal allergic rhinitis

Indexed keywords

FLUTICASONE PROPIONATE; LORATADINE;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NOSE AIRWAY RESISTANCE; NOSE CONGESTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0030053291     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70303-2     Document Type: Article

References (11)

1. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J ALLERGY CLIN IMMUNOL 1988;81:984-91.
2. Kaliner M. Treatment of allergic rhinitis in the 1990s. In: Kaliner M, ed. Management of allergy in the 1990s. Toronto: Hans Huber, 1989:5-13.
3. Lozewicz S, Wang J, Duddle J, et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J ALLERGY CLIN IMMUNOL 1992;89:951-7.
4. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sabotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987;316:1506-10.
5. Phillipps GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med. 1990;84(suppl A):19-23.
6. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84(suppl A):25-9.
7. van As A, Bronsky E, Grossman J, Meltzer E, Ratner P, Reed C. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 1991;67:156-62.
8. Bryson HM, Faulds D. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992;43:760-75.
9. Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray terfenadine and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy 1994;24:1144-50.
10. vanBaval J, Findlay SR, Hampel FC, Martin BG, Ratner P, Field E. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994;154:2699-704.
11. Stricker WE, Klimas JT, Mendelson L, et al. Intranasal fluticasone propionate is more effective than astemizole for seasonal allergic rhinitis [Abstract]. Ann Allergy 1994;72:86.